MedPath

A liquid biopsy study of recurrent gastric/gastroesophageal junction cancer

Not Applicable
Conditions
gastric or gastroesophageal junction cancer
Registration Number
JPRN-UMIN000043080
Lead Sponsor
St.Marianna University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Has other malignancy (excluding intraepithelial cancer) within 2 years. (2) The patient is not expected to survive for more than 12 weeks. (3) The principal investigator judges that participation in this study is inappropriate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The detection rate of therapeutic target genetic alterations in ctDNA
Secondary Outcome Measures
NameTimeMethod
The genetic profiles detected by ctDNA The genetic profile obtained by gene panel test using primary tumor tissue. Time from resection of the primary tumor to detection of recurrence. Progression-free survival and response rate for each treatment. Overall survival from the initiation of first-line chemotherapy.
© Copyright 2025. All Rights Reserved by MedPath